Skip to main content
SpringerLink
Log in

Adiponectin-Resistance in Obesity

  • Chapter
  • First Online:
Obesity and Lipotoxicity

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 960))

Abstract

The decrease in adiponectin levels are negatively correlated with chronic subclinical inflammation markers in obesity. The hypertrophic adipocytes cause obesity-linked insulin resistance and metabolic syndrome. Furthermore, macrophage polarization is a key determinant regulating adiponectin receptor (AdipoR1/R2) expression and differential adiponectin-mediated macrophage inflammatory responses in obese individuals. In addition to decrease in adiponectin concentrations, the decline in AdipoR1/R2 mRNA expression leads to a decrement in adiponectin binding to cell membrane, and this turns into attenuation in the adiponectin effects. Within the receptor complex, adaptor protein-containing pleckstrin homology domain, phosphotyrosine-binding domain, and leucine zipper motif 1 (APPL1) is the intracellular binding partner of AdipoR1 and AdipoR2. The expression levels of APPL1 or APPL2 lead to an altered adiponectin activity. Despite normal or high adiponectin levels, an impaired post receptor signaling due to APPL1/APPL2 may alter adiponectin efficiency and activity. However, APPL2 blocks adiponectin signaling through AdipoR1 and AdipoR2 by competitive inhibition of APPL1. APPL1 is also an important mediator of adiponectin dependent insulin sensitization. In this context, adiponectin resistance is associated with insulin resistance and is thought to be partly due to the down-regulation of the AdipoRs in high-fat diet fed subjects. Actually, adiponectin resistance occurs very rapidly after saturated fatty acid feeding, this metabolic disturbance is not due to a decrease in AdipoR1 protein content. Intra-abdominal adipose tissue-AdipoR2 expression is reduced in obesity, whereas AdipoR1 expression is not changed. Adiponectin resistance together with insulin resistance forms a vicious cycle. The elevated adiponectin levels with adiponectin resistance is a compensatory response in the condition of an unusual discordance between insulin resistance and adiponectin unresponsiveness.

Additionally, different mechanisms are involved in vascular adiponectin resistance at different stages of obesity. Nevertheless, diet-induced hyperlipidemia is the leading cause of vascular adiponectin resistance. Leptin/adiponectin imbalance may also be an important marker of the elevated risk of developing abdominal obesity-associated cardiovascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Addabbo, F., C. Nacci, L. De Benedictis, V. Leo, M. Tarquinio, M.J. Quon, and M. Montagnani. 2011. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells. American Journal of Physiology. Endocrinology and Metabolism 301: E1143–E1154. doi:10.1152/ajpendo.00208.2011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Adya, R., B.K. Tan, and H.S. Randeva. 2015. Differential effects of leptin and adiponectin in endothelial angiogenesis. Journal of Diabetes Research 2015: 648239. doi:10.1155/2015/648239.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Aprahamian, T.R. 2013. Elevated adiponectin expression promotes adipose tissue vascularity under conditions of diet-induced obesity. Metabolism 62: 1730–1738. doi:10.1016/j.metabol.2013.07.010.

    Article  CAS  PubMed  Google Scholar 

  • Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257: 79–83.

    Article  CAS  PubMed  Google Scholar 

  • Arner, E., P.O. Westermark, K.L. Spalding, T. Britton, M. Rydén, J. Frisén, S. Bernard, and P. Arner. 2010. Adipocyte turnover: Relevance to human adipose tissue morphology. Diabetes 59: 105–109. doi:10.2337/db09-0942.

    Article  CAS  PubMed  Google Scholar 

  • Bacha, F., R. Saad, N. Gungor, and S.A. Arslanian. 2004. Adiponectin in youth: Relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27: 547–552.

    Article  CAS  PubMed  Google Scholar 

  • Baffy, G. 2005. Uncoupling protein-2 and non-alcoholic fatty liver disease. Frontiers in Bioscience: A virtual library of medicine 10: 2082–2096.

    Article  CAS  Google Scholar 

  • Barbieri, M., A. Esposito, E. Angellotti, M.R. Rizzo, R. Marfella, and G. Paolisso. 2013. Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease. PLoS One 8: e71391. doi:10.1371/journal.pone.0071391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blachnio-Zabielska, A.U., C. Koutsari, T. Tchkonia, and M.D. Jensen. 2012. Sphingolipid content of human adipose tissue: Relationship to adiponectin and insulin resistance. Obesity (Silver Spring) 20: 2341–2347. doi:10.1038/oby.2012.126.

    Article  CAS  Google Scholar 

  • Blüher, M., M.D. Michael, O.D. Peroni, K. Ueki, N. Carter, B.B. Kahn, and C.R. Kahn. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 3: 25–38.

    Article  PubMed  Google Scholar 

  • Bobbert, T., J. Weicht, K. Mai, M. Möhlig, A.F.H. Pfeiffer, and J. Spranger. 2009. Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers. Clinical Endocrinology 71: 507–511. doi:10.1111/j.1365-2265.2008.03519.x.

    Article  CAS  PubMed  Google Scholar 

  • Bruce, C.R., V.A. Mertz, G.J.F. Heigenhauser, and D.J. Dyck. 2005. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54: 3154–3160.

    Article  CAS  PubMed  Google Scholar 

  • Bruun, J.M., A.S. Lihn, C. Verdich, S.B. Pedersen, S. Toubro, A. Astrup, and B. Richelsen. 2003. Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and Metabolism 285: E527–E533. doi:10.1152/ajpendo.00110.2003.

    Article  CAS  PubMed  Google Scholar 

  • Calvani, M., A. Scarfone, L. Granato, E.V. Mora, G. Nanni, M. Castagneto, A.V. Greco, M. Manco, and G. Mingrone. 2004. Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53: 939–947.

    Article  CAS  PubMed  Google Scholar 

  • Cao, Y., L. Tao, Y. Yuan, X. Jiao, W.B. Lau, Y. Wang, T. Christopher, B. Lopez, L. Chan, B. Goldstein, and X.L. Ma. 2009. Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. Journal of Molecular and Cellular Cardiology 46: 413–419. doi:10.1016/j.yjmcc.2008.10.014.

    Article  CAS  PubMed  Google Scholar 

  • Caselli, C. 2014. Role of adiponectin system in insulin resistance. Molecular Genetics and Metabolism 113: 155–160. doi:10.1016/j.ymgme.2014.09.003.

    Article  CAS  PubMed  Google Scholar 

  • Ceddia, R.B., R. Somwar, A. Maida, X. Fang, G. Bikopoulos, and G. Sweeney. 2005. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48: 132–139. doi:10.1007/s00125-004-1609-y.

    Article  CAS  PubMed  Google Scholar 

  • Chang, E., J.M. Choi, S.E. Park, E.-J. Rhee, W.-Y. Lee, K.-W. Oh, S.-W. Park, and C.-Y. Park. 2015. Adiponectin deletion impairs insulin signaling in insulin-sensitive but not insulin-resistant 3 T3-L1 adipocytes. Life Sciences 132: 93–100. doi:10.1016/j.lfs.2015.02.013.

    Article  CAS  PubMed  Google Scholar 

  • Chen, H., M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. The Journal of Biological Chemistry 278: 45021–45026. doi:10.1074/jbc.M307878200.

    Article  CAS  PubMed  Google Scholar 

  • Chen, M.B., A.J. McAinch, S.L. Macaulay, L.A. Castelli, P.E. O’brien, J.B. Dixon, D. Cameron-Smith, B.E. Kemp, and G.R. Steinberg. 2005. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. The Journal of Clinical Endocrinology and Metabolism 90: 3665–3672. doi:10.1210/jc.2004-1980.

    Article  CAS  PubMed  Google Scholar 

  • Chen, H., A. Fajol, M. Hoene, B. Zhang, E.D. Schleicher, Y. Lin, C. Calaminus, B.J. Pichler, C. Weigert, H.U. Häring, F. Lang, and M. Föller. 2016. PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 113: 5754–5759. doi:10.1073/pnas.1601355113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chinetti, G., C. Zawadski, J.C. Fruchart, and B. Staels. 2004. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochemical and Biophysical Research Communications 314: 151–158.

    Article  CAS  PubMed  Google Scholar 

  • Chou, I.-P., Y.-P. Chiu, S.-T. Ding, B.-H. Liu, Y.Y. Lin, and C.-Y. Chen. 2014a. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice—Possible involvement of oxidative stress and autophagy. Endocrine Research 39: 173–179. doi:10.3109/07435800.2013.879165.

    Article  CAS  PubMed  Google Scholar 

  • Chou, I.-P., Y.Y. Lin, S.-T. Ding, and C.-Y. Chen. 2014b. Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway. European Journal of Nutrition 53: 907–917. doi:10.1007/s00394-013-0594-7.

    Article  CAS  PubMed  Google Scholar 

  • Cleasby, M.E., Q. Lau, E. Polkinghorne, S.A. Patel, S.J. Leslie, N. Turner, G.J. Cooney, A. Xu, and E.W. Kraegen. 2011. The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway. The Journal of Endocrinology 210: 81–92. doi:10.1530/JOE-11-0039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui, X.-B., C. Wang, L. Li, D. Fan, Y. Zhou, D. Wu, Q.-H. Cui, F.-Y. Fu, and L.-L. Wu. 2012. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway. Cardiovascular Research 93: 69–78. doi:10.1093/cvr/cvr273.

    Article  CAS  PubMed  Google Scholar 

  • Curtis, J.M., W.S. Hahn, M.D. Stone, J.J. Inda, D.J. Droullard, J.P. Kuzmicic, M.A. Donoghue, E.K. Long, A.G. Armien, S. Lavandero, E. Arriaga, T.J. Griffin, and D.A. Bernlohr. 2012. Protein carbonylation and adipocyte mitochondrial function. The Journal of Biological Chemistry 287: 32967–32980. doi:10.1074/jbc.M112.400663.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dallaire, P., K. Bellmann, M. Laplante, S. Gélinas, C. Centeno-Baez, P. Penfornis, M.-L. Peyot, M.G. Latour, J. Lamontagne, M.E. Trujillo, P.E. Scherer, M. Prentki, Y. Deshaies, and A. Marette. 2008. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57: 1999–2011. doi:10.2337/db08-0540.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deepa, S.S., and L.Q. Dong. 2009. APPL1: Role in adiponectin signaling and beyond. American Journal of Physiology. Endocrinology and Metabolism 296: E22–E36. doi:10.1152/ajpendo.90731.2008.

    Article  CAS  PubMed  Google Scholar 

  • Delaigle, A.M., J.-C. Jonas, I.B. Bauche, O. Cornu, and S.M. Brichard. 2004. Induction of adiponectin in skeletal muscle by inflammatory cytokines: In vivo and in vitro studies. Endocrinology 145: 5589–5597. doi:10.1210/en.2004-0503.

    Article  CAS  PubMed  Google Scholar 

  • Denzel, M.S., M.-C. Scimia, P.M. Zumstein, K. Walsh, P. Ruiz-Lozano, and B. Ranscht. 2010. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. The Journal of Clinical Investigation 120: 4342–4352. doi:10.1172/JCI43464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ding, Q., Z. Wang, and Y. Chen. 2009. Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway. Cell Research 19: 317–327. doi:10.1038/cr.2008.299.

    Article  CAS  PubMed  Google Scholar 

  • Dokken, B.B., and E.J. Henriksen. 2006. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats. American Journal of Physiology. Endocrinology and Metabolism 291: E207–E213. doi:10.1152/ajpendo.00628.2005.

    Article  CAS  PubMed  Google Scholar 

  • Dordevic, A.L., N. Konstantopoulos, and D. Cameron-Smith. 2014. 3T3-L1 preadipocytes exhibit heightened monocyte-chemoattractant protein-1 response to acute fatty acid exposure. PLoS One 9: e99382. doi:10.1371/journal.pone.0099382.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Drolet, R., C. Bélanger, M. Fortier, C. Huot, J. Mailloux, D. Légaré, and A. Tchernof. 2009. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 17: 424–430. doi:10.1038/oby.2008.555.

    Article  CAS  Google Scholar 

  • Engfeldt, P., and P. Arner. 1988. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Hormone and Metabolic Research. Supplement Series 19: 26–29.

    CAS  PubMed  Google Scholar 

  • Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, Thong FS, Tuinei J, Xu A, Abel ED, Sweeney G. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E721–9.

    Google Scholar 

  • Fiaschi, T., F. Buricchi, G. Cozzi, S. Matthias, M. Parri, G. Raugei, G. Ramponi, and P. Chiarugi. 2007. Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin. Hepatology 46: 130–139. doi:10.1002/hep.21643.

    Article  CAS  PubMed  Google Scholar 

  • Frohnert, B.I., and D.A. Bernlohr. 2013. Protein carbonylation, mitochondrial dysfunction, and insulin resistance. Advances in Nutrition 4: 157–163. doi:10.3945/an.112.003319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gajewska, J., H. Weker, J. Ambroszkiewicz, M. Chełchowska, M. Więch, and T. Laskowska-Klita. 2011. Changes in concentration of serum adiponectin multimeric forms following weight reduction programme in prepubertal obese children. Medycyna Wieku Rozwojowego 15: 298–305.

    PubMed  Google Scholar 

  • Gallo, S., G. Egeland, S. Meltzer, L. Legault, and S. Kubow. 2010. Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. The Journal of Clinical Endocrinology and Metabolism 95: 2410–2417. doi:10.1210/jc.2009-1975.

    Article  CAS  PubMed  Google Scholar 

  • Gauthier, M.-S., E.L. O’Brien, S. Bigornia, M. Mott, J.M. Cacicedo, X.J. Xu, N. Gokce, C. Apovian, and N. Ruderman. 2011. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochemical and Biophysical Research Communications 404: 382–387. doi:10.1016/j.bbrc.2010.11.127.

    Article  CAS  PubMed  Google Scholar 

  • Goldstein, B.J., R.G. Scalia, and X.L. Ma. 2009. Protective vascular and myocardial effects of adiponectin. Nature Clinical Practice. Cardiovascular Medicine 6: 27–35. doi:10.1038/ncpcardio1398.

    Article  CAS  PubMed  Google Scholar 

  • Groeneveld, M.P., G.V. Brierley, N.M. Rocha, K. Siddle, and R.K. Semple. 2016. Acute knockdown of the insulin receptor or its substrates Irs1 and 2 in 3 T3-L1 adipocytes suppresses adiponectin production. Scientific Reports 6: 21105. doi:10.1038/srep21105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gu, D., Z. Wang, X. Dou, X. Zhang, S. Li, L. Vu, T. Yao, and Z. Song. 2013. Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin-proteasome system: Relevance to obesity-related adiponectin decline. Metabolism 62: 1137–1148. doi:10.1016/j.metabol.2013.01.025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henriksen, E.J. 2010. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes. Current Diabetes Reviews 6: 285–293.

    Article  CAS  PubMed  Google Scholar 

  • Henriksen, E.J., and B.B. Dokken. 2006. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Current Drug Targets 7: 1435–1441.

    Article  CAS  PubMed  Google Scholar 

  • Hino, K., and H. Nagata. 2012. Screening for adiponectin secretion regulators. Vitamins and Hormones 90: 125–141. doi:10.1016/B978-0-12-398313-8.00005-1.

    Article  CAS  PubMed  Google Scholar 

  • Høeg, L.D., K.A. Sjøberg, A.-M. Lundsgaard, A.B. Jordy, N. Hiscock, J.F.P. Wojtaszewski, E.A. Richter, and B. Kiens. 2013. Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women. Journal of Applied Physiology (1985) 114: 592–601. doi:10.1152/japplphysiol.01046.2012.

    Article  CAS  Google Scholar 

  • Hoffmann, A., T. Ebert, N. Klöting, J. Dokas, F. Jeromin, B. Jessnitzer, R. Burkhardt, M. Fasshauer, and S. Kralisch. 2016. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin. Biochimica et Biophysica Acta 1862: 113–120. doi:10.1016/j.bbadis.2015.10.022.

    Article  CAS  PubMed  Google Scholar 

  • Holland, W.L., and S.A. Summers. 2008. Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism. Endocrine Reviews 29: 381–402. doi:10.1210/er.2007-0025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holland, W.L., R.A. Miller, Z.V. Wang, K. Sun, B.M. Barth, H.H. Bui, K.E. Davis, B.T. Bikman, N. Halberg, J.M. Rutkowski, M.R. Wade, V.M. Tenorio, M.-S. Kuo, J.T. Brozinick, B.B. Zhang, M.J. Birnbaum, S.A. Summers, and P.E. Scherer. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine 17: 55–63. doi:10.1038/nm.2277.

    Article  CAS  PubMed  Google Scholar 

  • Hosch, S.E., J.M. Olefsky, and J.J. Kim. 2006. APPLied mechanics: Uncovering how adiponectin modulates insulin action. Cell Metabolism 4: 5–6. doi:10.1016/j.cmet.2006.06.003.

    Article  CAS  PubMed  Google Scholar 

  • Hossain, M.M., A. Mukheem, and T. Kamarul. 2015. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. Life Sciences 135: 55–67. doi:10.1016/j.lfs.2015.03.010.

    Article  CAS  PubMed  Google Scholar 

  • Hou, M., Z. Chu, T. Liu, H. Lv, L. Sun, B. Wang, J. Huang, and W. Yan. 2015. A high-fat maternal diet decreases adiponectin receptor-1 expression in offspring. The Journal of Maternal-Fetal & Neonatal Medicine 28: 216–221. doi:10.3109/14767058.2014.914489.

    Article  CAS  Google Scholar 

  • Hu, E., P. Liang, and B.M. Spiegelman. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. The Journal of Biological Chemistry 271: 10697–10703.

    Article  CAS  PubMed  Google Scholar 

  • Huang, P.-H., J.-S. Chen, H.-Y. Tsai, Y.-H. Chen, F.-Y. Lin, H.-B. Leu, T.-C. Wu, S.-J. Lin, and J.-W. Chen. 2011. Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. Journal of Molecular and Cellular Cardiology 51: 109–119. doi:10.1016/j.yjmcc.2011.03.008.

    Article  PubMed  CAS  Google Scholar 

  • Hug, C., J. Wang, N.S. Ahmad, J.S. Bogan, T.-S. Tsao, and H.F. Lodish. 2004. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America 101: 10308–10313. doi:10.1073/pnas.0403382101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jeon, M.J., J. Leem, M.S. Ko, J.E. Jang, H.-S. Park, H.S. Kim, M. Kim, E.H. Kim, H.J. Yoo, C.-H. Lee, I.-S. Park, K.-U. Lee, and E.H. Koh. 2012. Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes. Experimental & Molecular Medicine 44: 562–570. doi:10.3858/emm.2012.44.9.064.

    Article  CAS  Google Scholar 

  • Jiao, P., Q. Chen, S. Shah, J. Du, B. Tao, I. Tzameli, W. Yan, and H. Xu. 2009. Obesity-related upregulation of monocyte chemotactic factors in adipocytes: Involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58: 104–115. doi:10.2337/db07-1344.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kadowaki, T., and T. Yamauchi. 2005. Adiponectin and adiponectin receptors. Endocrine Reviews 26: 439–451. doi:10.1210/er.2005-0005.

    Article  CAS  PubMed  Google Scholar 

  • Kanda, H., S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The Journal of Clinical Investigation 116: 1494–1505. doi:10.1172/JCI26498.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Karki, S., P. Chakrabarti, G. Huang, H. Wang, S.R. Farmer, and K.V. Kandror. 2011. The multi-level action of fatty acids on adiponectin production by fat cells. PLoS One 6: e28146. doi:10.1371/journal.pone.0028146.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim, C.-H., P. Pennisi, H. Zhao, S. Yakar, J.B. Kaufman, K. Iganaki, J. Shiloach, P.E. Scherer, M.J. Quon, and D. LeRoith. 2006. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: Discordance between insulin resistance and adiponectin responsiveness. American Journal of Physiology. Endocrinology and Metabolism 291: E298–E305. doi:10.1152/ajpendo.00319.2005.

    Article  CAS  PubMed  Google Scholar 

  • Kim, A.Y., Y.J. Park, X. Pan, K.C. Shin, S.-H. Kwak, A.F. Bassas, R.M. Sallam, K.S. Park, A.A. Alfadda, A. Xu, and J.B. Kim. 2015. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nature Communications 6: 7585. doi:10.1038/ncomms8585.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kitamura, Y.I., T. Kitamura, J.-P. Kruse, J.C. Raum, R. Stein, W. Gu, and D. Accili. 2005. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metabolism 2: 153–163. doi:10.1016/j.cmet.2005.08.004.

    Article  CAS  PubMed  Google Scholar 

  • Koh, E.H., J.-Y. Park, H.-S. Park, M.J. Jeon, J.W. Ryu, M. Kim, S.Y. Kim, M.-S. Kim, S.-W. Kim, I.S. Park, J.H. Youn, and K.-U. Lee. 2007. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56: 2973–2981. doi:10.2337/db07-0510.

    Article  CAS  PubMed  Google Scholar 

  • Kopp, H.-P., K. Krzyzanowska, M. Möhlig, J. Spranger, A.F.H. Pfeiffer, and G. Schernthaner. 2005. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. International Journal of Obesity 2005(29): 766–771. doi:10.1038/sj.ijo.0802983.

    Article  CAS  Google Scholar 

  • Kumagai, S., H. Kishimoto, Masatakasuwa, B. Zou, and Harukasasaki. 2005. The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metabolic Syndrome and Related Disorders 3: 85–94. doi:10.1089/met.2005.3.85.

    Article  CAS  PubMed  Google Scholar 

  • Labruna, G., F. Pasanisi, C. Nardelli, R. Caso, D.F. Vitale, F. Contaldo, and L. Sacchetti. 2011. High leptin/adiponectin ratio and serum triglycerides are associated with an “at-risk” phenotype in young severely obese patients. Obesity (Silver Spring) 19: 1492–1496. doi:10.1038/oby.2010.309.

    Article  CAS  Google Scholar 

  • Lau, W.B., L. Tao, Y. Wang, R. Li, and X.L. Ma. 2011. Systemic adiponectin malfunction as a risk factor for cardiovascular disease. Antioxidants & Redox Signaling 15: 1863–1873. doi:10.1089/ars.2010.3743.

    Article  CAS  Google Scholar 

  • Lee, M.-J., R.-Z. Yang, K. Karastergiou, S.R. Smith, J.R. Chang, D.-W. Gong, and S.K. Fried. 2016. Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity. Journal of Lipid Research 57: 1256–1263. doi:10.1194/jlr.M067728.

    Article  CAS  PubMed  Google Scholar 

  • Li, R., W.-Q. Wang, H. Zhang, X. Yang, Q. Fan, T.A. Christopher, B.L. Lopez, L. Tao, B.J. Goldstein, F. Gao, and X.L. Ma. 2007. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. American Journal of Physiology. Endocrinology and Metabolism 293: E1703–E1708. doi:10.1152/ajpendo.00462.2007.

    Article  CAS  PubMed  Google Scholar 

  • Li, R., W.B. Lau, and X.L. Ma. 2010a. Adiponectin resistance and vascular dysfunction in the hyperlipidemic state. Acta Pharmacologica Sinica 31: 1258–1266. doi:10.1038/aps.2010.95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li, R., M. Xu, X. Wang, Y. Wang, W.B. Lau, Y. Yuan, W. Yi, X. Wei, B.L. Lopez, T.A. Christopher, X.-M. Wang, and X.-L. Ma. 2010b. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats—Mechanisms and significance. Journal of Molecular and Cellular Cardiology 49: 508–515. doi:10.1016/j.yjmcc.2010.03.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li, F.Y.L., K.K.Y. Cheng, K.S.L. Lam, P.M. Vanhoutte, and A. Xu. 2011. Cross-talk between adipose tissue and vasculature: Role of adiponectin. Acta Physiologica (Oxford, England) 203: 167–180. doi:10.1111/j.1748-1716.2010.02216.x.

    Article  CAS  Google Scholar 

  • Lin, H.V., J.-Y. Kim, A. Pocai, L. Rossetti, L. Shapiro, P.E. Scherer, and D. Accili. 2007. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 56: 1969–1976. doi:10.2337/db07-0127.

    Article  CAS  PubMed  Google Scholar 

  • López-Jaramillo, P., D. Gómez-Arbeláez, J. López-López, C. López-López, J. Martínez-Ortega, A. Gómez-Rodríguez, and S. Triana-Cubillos. 2014. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone Molecular Biology and Clinical Investigation 18: 37–45. doi:10.1515/hmbci-2013-0053.

    Article  PubMed  CAS  Google Scholar 

  • Mai, S., G.E. Walker, A. Brunani, G. Guzzaloni, G. Grossi, A. Oldani, G. Aimaretti, M. Scacchi, and P. Marzullo. 2014. Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity. Scientific Reports 4: 5803. doi:10.1038/srep05803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mao, X., C.K. Kikani, R.A. Riojas, P. Langlais, L. Wang, F.J. Ramos, Q. Fang, C.Y. Christ-Roberts, J.Y. Hong, R.-Y. Kim, F. Liu, and L.Q. Dong. 2006. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nature Cell Biology 8: 516–523. doi:10.1038/ncb1404.

    Article  CAS  PubMed  Google Scholar 

  • Matafome, P., T. Rodrigues, A. Pereira, L. Letra, H. Azevedo, A. Paixão, M. Silvério, A. Almeida, C. Sena, and R. Seiça. 2014. Long-term globular adiponectin administration improves adipose tissue dysmetabolism in high-fat diet-fed Wistar rats. Archives of Physiology and Biochemistry 120: 147–157. doi:10.3109/13813455.2014.950590.

    Article  CAS  PubMed  Google Scholar 

  • Matsuda, M., and I. Shimomura. 2014. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Reviews in Endocrine & Metabolic Disorders 15: 1–10. doi:10.1007/s11154-013-9271-7.

    Article  CAS  Google Scholar 

  • McAinch, A.J., G.R. Steinberg, J. Mollica, P.E. O’Brien, J.B. Dixon, S.L. Macaulay, B.E. Kemp, and D. Cameron-Smith. 2006. Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity (Silver Spring) 14: 1898–1904. doi:10.1038/oby.2006.221.

    Article  CAS  Google Scholar 

  • Medina-Urrutia, A., C. Posadas-Romero, R. Posadas-Sánchez, E. Jorge-Galarza, T. Villarreal-Molina, M.D.C. González-Salazar, G. Cardoso-Saldaña, G. Vargas-Alarcón, M. Torres-Tamayo, and J.G. Juárez-Rojas. 2015. Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance. Cardiovascular Diabetology 14: 20. doi:10.1186/s12933-015-0184-5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meyer, L.K., T.P. Ciaraldi, R.R. Henry, A.C. Wittgrove, and S.A. Phillips. 2013. Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity. Adipocytes 2: 217–226. doi:10.4161/adip.24953.

    Article  Google Scholar 

  • Miyazaki, S., T. Izawa, J. Ogasawara, T. Sakurai, S. Nomura, T. Kizaki, H. Ohno, and T. Komabayashi. 2010. Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sciences 86: 691–698. doi:10.1016/j.lfs.2010.03.004.

    Article  CAS  PubMed  Google Scholar 

  • Mohazzab, K.M., P.M. Kaminski, and M.S. Wolin. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. The American Journal of Physiology 266: H2568–H2572.

    CAS  PubMed  Google Scholar 

  • Mondal, A.K., S.K. Das, V. Varma, G.T. Nolen, R.E. McGehee, S.C. Elbein, J.Y. Wei, and G. Ranganathan. 2012. Effect of endoplasmic reticulum stress on inflammation and adiponectin regulation in human adipocytes. Metabolic Syndrome and Related Disorders 10: 297–306. doi:10.1089/met.2012.0002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morínigo, R., M. Musri, J. Vidal, R. Casamitjana, S. Delgado, A.M. Lacy, C. Ayuso, R. Gomis, and H. Corominola. 2006. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obesity Surgery 16: 745–751. doi:10.1381/096089206777346736.

    Article  PubMed  Google Scholar 

  • Motoshima, H., X. Wu, M.K. Sinha, V.E. Hardy, E.L. Rosato, D.J. Barbot, F.E. Rosato, and B.J. Goldstein. 2002. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone. The Journal of Clinical Endocrinology and Metabolism 87: 5662–5667. doi:10.1210/jc.2002-020635.

    Article  CAS  PubMed  Google Scholar 

  • Motoshima, H., X. Wu, K. Mahadev, and B.J. Goldstein. 2004. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochemical and Biophysical Research Communications 315: 264–271. doi:10.1016/j.bbrc.2004.01.049.

    Article  CAS  PubMed  Google Scholar 

  • Mullen, K.L., A.C. Smith, K.A. Junkin, and D.J. Dyck. 2007. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. American Journal of Physiology. Endocrinology and Metabolism 293: E83–E90. doi:10.1152/ajpendo.00545.2006.

    Article  CAS  PubMed  Google Scholar 

  • Mullen, K.L., J. Pritchard, I. Ritchie, L.A. Snook, A. Chabowski, A. Bonen, D. Wright, and D.J. Dyck. 2009. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 296: R243–R251. doi:10.1152/ajpregu.90774.2008.

    Article  CAS  PubMed  Google Scholar 

  • Netzer, N., H. Gatterer, M. Faulhaber, M. Burtscher, S. Pramsohler, and D. Pesta. 2015. Hypoxia, oxidative stress and fat. Biomolecules 5: 1143–1150. doi:10.3390/biom5021143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ohashi, K., J.L. Parker, N. Ouchi, A. Higuchi, J.A. Vita, N. Gokce, A.A. Pedersen, C. Kalthoff, S. Tullin, A. Sams, R. Summer, and K. Walsh. 2010. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. The Journal of Biological Chemistry 285: 6153–6160. doi:10.1074/jbc.M109.088708.

    Article  CAS  PubMed  Google Scholar 

  • Okada-Iwabu, M., T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami, K. Matsuda, M. Yamaguchi, H. Tanabe, T. Kimura-Someya, M. Shirouzu, H. Ogata, K. Tokuyama, K. Ueki, T. Nagano, A. Tanaka, S. Yokoyama, and T. Kadowaki. 2013. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503: 493–499. doi:10.1038/nature12656.

    Article  CAS  PubMed  Google Scholar 

  • Ouchi, N., S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, S. Yamashita, T. Funahashi, and Y. Matsuzawa. 1999. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100: 2473–2476.

    Article  CAS  PubMed  Google Scholar 

  • Ouchi, N., H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, T. Funahashi, and K. Walsh. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. The Journal of Biological Chemistry 279: 1304–1309. doi:10.1074/jbc.M310389200.

    Article  CAS  PubMed  Google Scholar 

  • Ouedraogo, R., X. Wu, S.-Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, and B.J. Goldstein. 2006. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: Evidence for involvement of a cAMP signaling pathway. Diabetes 55: 1840–1846. doi:10.2337/db05-1174.

    Article  CAS  PubMed  Google Scholar 

  • Ozen, G., A. Daci, X. Norel, and G. Topal. 2015. Human perivascular adipose tissue dysfunction as a cause of vascular disease: Focus on vascular tone and wall remodeling. European Journal of Pharmacology 766: 16–24. doi:10.1016/j.ejphar.2015.09.012.

    Article  CAS  PubMed  Google Scholar 

  • Pajvani, U.B., X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, T. Schulthess, J. Engel, M. Brownlee, and P.E. Scherer. 2003. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. The Journal of Biological Chemistry 278: 9073–9085. doi:10.1074/jbc.M207198200.

    Article  CAS  PubMed  Google Scholar 

  • Park, S., S.-Y. Oh, M.-Y. Lee, S. Yoon, K.-S. Kim, and J. Kim. 2004. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53: 2757–2766.

    Article  CAS  PubMed  Google Scholar 

  • Park, H.J., Y.M. Kang, C.H. Kim, and M.H. Jung. 2010. ATF3 negatively regulates adiponectin receptor 1 expression. Biochemical and Biophysical Research Communications 400: 72–77. doi:10.1016/j.bbrc.2010.08.011.

    Article  CAS  PubMed  Google Scholar 

  • Park, M., A. Sabetski, Y. Kwan Chan, S. Turdi, and G. Sweeney. 2015. Palmitate induces ER stress and autophagy in H9c2 cells: Implications for apoptosis and adiponectin resistance. Journal of Cellular Physiology 230: 630–639. doi:10.1002/jcp.24781.

    Article  CAS  PubMed  Google Scholar 

  • Parker-Duffen, J.L., K. Nakamura, M. Silver, M.A. Zuriaga, S. MacLauchlan, T.R. Aprahamian, and K. Walsh. 2014. Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo. The Journal of Biological Chemistry 289: 16200–16213. doi:10.1074/jbc.M114.548115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel, S.A., K.L. Hoehn, R.T. Lawrence, L. Sawbridge, N.A. Talbot, J.L. Tomsig, N. Turner, G.J. Cooney, J.P. Whitehead, E.W. Kraegen, and M.E. Cleasby. 2012. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. Endocrinology 153: 5231–5246. doi:10.1210/en.2012-1368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peti, A., A. Juhasz, P. Kenyeres, Z. Varga, I. Seres, G.L. Kovacs, G. Paragh, and L. Bajnok. 2011. Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals. Journal of Endocrinological Investigation 34: 21–25. doi:10.1007/BF03346690.

    Article  CAS  PubMed  Google Scholar 

  • Qiao, L., B. Kinney, H.S. Yoo, B. Lee, J. Schaack, and J. Shao. 2012. Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1. Diabetes 61: 1463–1470. doi:10.2337/db11-1475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rasmussen, M.S., A.S. Lihn, S.B. Pedersen, J.M. Bruun, M. Rasmussen, and B. Richelsen. 2006. Adiponectin receptors in human adipose tissue: Effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 14: 28–35. doi:10.1038/oby.2006.5.

    Article  CAS  Google Scholar 

  • Ross, R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801–809. doi:10.1038/362801a0.

    Article  CAS  PubMed  Google Scholar 

  • Ruan, H., and L.Q. Dong. 2016. Adiponectin signaling and function in insulin target tissues. Journal of Molecular Cell Biology 8: 101–109. doi:10.1093/jmcb/mjw014.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ryo, M., T. Nakamura, S. Kihara, M. Kumada, S. Shibazaki, M. Takahashi, M. Nagai, Y. Matsuzawa, and T. Funahashi. 2004. Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 68: 975–981.

    Article  CAS  PubMed  Google Scholar 

  • Ryu, J., A.K. Galan, X. Xin, F. Dong, M.A. Abdul-Ghani, L. Zhou, C. Wang, C. Li, B.M. Holmes, L.B. Sloane, S.N. Austad, S. Guo, N. Musi, R.A. DeFronzo, C. Deng, M.F. White, F. Liu, and L.Q. Dong. 2014. APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor. Cell Reports 7: 1227–1238. doi:10.1016/j.celrep.2014.04.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saito, Y., D. Fujioka, K. Kawabata, T. Kobayashi, T. Yano, T. Nakamura, Y. Kodama, H. Takano, Y. Kitta, J. Obata, and K. Kugiyama. 2007a. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake. American Journal of Physiology. Heart and Circulatory Physiology 293: H3490–H3497. doi:10.1152/ajpheart.00310.2007.

    Article  CAS  PubMed  Google Scholar 

  • Saito, T., C.C. Jones, S. Huang, M.P. Czech, and P.F. Pilch. 2007b. The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. The Journal of Biological Chemistry 282: 32280–32287. doi:10.1074/jbc.M704150200.

    Article  CAS  PubMed  Google Scholar 

  • Salman, A., M. Hegazy, and S. AbdElfadl. 2015. Combined adiponectin deficiency and resistance in obese patients: Can it solve part of the puzzle in nonalcoholic steatohepatitis. Open Access Macedonian Journal of Medical Sciences 3: 298–302. doi:10.3889/oamjms.2015.057.

    Article  PubMed  PubMed Central  Google Scholar 

  • Scherer, P.E., S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry 270: 26746–26749.

    Article  CAS  PubMed  Google Scholar 

  • Schmid, P.M., M. Resch, A. Steege, S. Fredersdorf-Hahn, B. Stoelcker, C. Birner, C. Schach, C. Buechler, G.A.J. Riegger, A. Luchner, and D.H. Endemann. 2011. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats. American Journal of Hypertension 24: 270–277. doi:10.1038/ajh.2010.239.

    Article  CAS  PubMed  Google Scholar 

  • Semple, R.K., M.A. Soos, J. Luan, C.S. Mitchell, J.C. Wilson, M. Gurnell, E.K. Cochran, P. Gorden, V.K.K. Chatterjee, N.J. Wareham, and S. O’Rahilly. 2006. Elevated plasma adiponectin in humans with genetically defective insulin receptors. The Journal of Clinical Endocrinology and Metabolism 91: 3219–3223. doi:10.1210/jc.2006-0166.

    Article  CAS  PubMed  Google Scholar 

  • Semple, R.K., N.H. Halberg, K. Burling, M.A. Soos, T. Schraw, J. Luan, E.K. Cochran, D.B. Dunger, N.J. Wareham, P.E. Scherer, P. Gorden, and S. O’Rahilly. 2007. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56: 1712–1717. doi:10.2337/db06-1665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sente, T., A.M. Van Berendoncks, V.Y. Hoymans, and C.J. Vrints. 2016. Adiponectin resistance in skeletal muscle: Pathophysiological implications in chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle 7: 261–274. doi:10.1002/jcsm.12086.

    Article  PubMed  Google Scholar 

  • Shi, X., W. Shi, Q. Li, B. Song, M. Wan, S. Bai, and X. Cao. 2003. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Reports 4: 374–380. doi:10.1038/sj.embor.embor805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shibata, R., N. Ouchi, and T. Murohara. 2009. Adiponectin and cardiovascular disease. Circulation Journal 73: 608–614.

    Article  CAS  PubMed  Google Scholar 

  • Shimizu, T., M. Yamakuchi, K.K. Biswas, B. Aryal, S. Yamada, T. Hashiguchi, and I. Maruyama. 2016. HMGB1 is secreted by 3 T3-L1 adipocytes through JNK signaling and the secretion is partially inhibited by adiponectin. Obesity (Silver Spring) 24: 1913–1921. doi:10.1002/oby.21549.

    Article  CAS  Google Scholar 

  • Singh, P., P. Sharma, K.R. Sahakyan, D.E. Davison, F.H. Sert-Kuniyoshi, A. Romero-Corral, J.M. Swain, M.D. Jensen, F. Lopez-Jimenez, T. Kara, and V.K. Somers. 2016. Differential effects of leptin on adiponectin expression with weight gain versus obesity. International Journal of Obesity 2005(40): 266–274. doi:10.1038/ijo.2015.181.

    Article  CAS  Google Scholar 

  • Stanley, W.C., F.A. Recchia, and G.D. Lopaschuk. 2005. Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews 85: 1093–1129. doi:10.1152/physrev.00006.2004.

    Article  CAS  PubMed  Google Scholar 

  • Steinberg, G.R., A.J. McAinch, M.B. Chen, P.E. O’Brien, J.B. Dixon, D. Cameron-Smith, and B.E. Kemp. 2006. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. The Journal of Clinical Endocrinology and Metabolism 91: 3592–3597. doi:10.1210/jc.2006-0638.

    Article  CAS  PubMed  Google Scholar 

  • Subauste, A.R., and C.F. Burant. 2007. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. American Journal of Physiology. Endocrinology and Metabolism 293: E159–E164. doi:10.1152/ajpendo.00629.2006.

    Article  CAS  PubMed  Google Scholar 

  • Tanabe, H., Y. Fujii, M. Okada-Iwabu, M. Iwabu, Y. Nakamura, T. Hosaka, K. Motoyama, M. Ikeda, M. Wakiyama, T. Terada, N. Ohsawa, M. Hato, S. Ogasawara, T. Hino, T. Murata, S. Iwata, K. Hirata, Y. Kawano, M. Yamamoto, T. Kimura-Someya, M. Shirouzu, T. Yamauchi, T. Kadowaki, and S. Yokoyama. 2015. Crystal structures of the human adiponectin receptors. Nature 520: 312–316. doi:10.1038/nature14301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tao, L., E. Gao, X. Jiao, Y. Yuan, S. Li, T.A. Christopher, B.L. Lopez, W. Koch, L. Chan, B.J. Goldstein, and X.L. Ma. 2007. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115: 1408–1416. doi:10.1161/CIRCULATIONAHA.106.666941.

    Article  CAS  PubMed  Google Scholar 

  • Tomas, E., T.-S. Tsao, A.K. Saha, H.E. Murrey, Zhang Cc Cc, S.I. Itani, H.F. Lodish, and N.B. Ruderman. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 99: 16309–16313. doi:10.1073/pnas.222657499.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsao, T.-S., E. Tomas, H.E. Murrey, C. Hug, D.H. Lee, N.B. Ruderman, J.E. Heuser, and H.F. Lodish. 2003. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. The Journal of Biological Chemistry 278: 50810–50817. doi:10.1074/jbc.M309469200.

    Article  CAS  PubMed  Google Scholar 

  • Tsuchida, A., T. Yamauchi, Y. Ito, Y. Hada, T. Maki, S. Takekawa, J. Kamon, M. Kobayashi, R. Suzuki, K. Hara, N. Kubota, Y. Terauchi, P. Froguel, J. Nakae, M. Kasuga, D. Accili, K. Tobe, K. Ueki, R. Nagai, and T. Kadowaki. 2004. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. The Journal of Biological Chemistry 279: 30817–30822. doi:10.1074/jbc.M402367200.

    Article  CAS  PubMed  Google Scholar 

  • Tsuchida, A., T. Yamauchi, S. Takekawa, Y. Hada, Y. Ito, T. Maki, and T. Kadowaki. 2005. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: Comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes 54: 3358–3370.

    Article  CAS  PubMed  Google Scholar 

  • Unger, R.H. 2002. Lipotoxic diseases. Annual Review of Medicine 53: 319–336. doi:10.1146/annurev.med.53.082901.104057.

    Article  CAS  PubMed  Google Scholar 

  • Unger, R.H., P.E. Scherer, and W.L. Holland. 2013. Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine. Molecular Biology of the Cell 24: 3011–3015. doi:10.1091/mbc.E12-10-0774.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van Stijn, C.M.W., J. Kim, A.J. Lusis, G.D. Barish, and R.K. Tangirala. 2015. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response. The FASEB Journal 29: 636–649. doi:10.1096/fj.14-253831.

    Article  PubMed  CAS  Google Scholar 

  • Vilarrasa, N., J. Vendrell, R. Sánchez-Santos, M. Broch, A. Megia, C. Masdevall, N. Gomez, J. Soler, J. Pujol, C. Bettónica, H. Aranda, and J.M. Gómez. 2007. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clinical Endocrinology 67: 679–686. doi:10.1111/j.1365-2265.2007.02945.x.

    Article  CAS  PubMed  Google Scholar 

  • Viollet, B., R. Mounier, J. Leclerc, A. Yazigi, M. Foretz, and F. Andreelli. 2007. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes & Metabolism 33: 395–402. doi:10.1016/j.diabet.2007.10.004.

    Article  CAS  Google Scholar 

  • Waki, H., T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, S. Kimura, R. Nagai, and T. Kadowaki. 2003. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. The Journal of Biological Chemistry 278: 40352–40363. doi:10.1074/jbc.M300365200.

    Article  CAS  PubMed  Google Scholar 

  • Walton, R.G., B. Zhu, R. Unal, M. Spencer, M. Sunkara, A.J. Morris, R. Charnigo, W.S. Katz, A. Daugherty, D.A. Howatt, P.A. Kern, and B.S. Finlin. 2015. Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity. The Journal of Biological Chemistry 290: 11547–11556. doi:10.1074/jbc.M114.628487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang, B., Y. Yu, and L. Han. 2012. Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway. Diabetes Research and Clinical Practice 97: 119–124. doi:10.1016/j.diabres.2012.02.009.

    Article  CAS  PubMed  Google Scholar 

  • Wang, Y., X. Wang, W.B. Lau, Y. Yuan, D. Booth, J.-J. Li, R. Scalia, K. Preston, E. Gao, W. Koch, and X.-L. Ma. 2014. Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation. Circulation Research 114: 792–805. doi:10.1161/CIRCRESAHA.114.302439.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weisberg, S.P., D. Hunter, R. Huber, J. Lemieux, S. Slaymaker, K. Vaddi, I. Charo, R.L. Leibel, and A.W. Ferrante. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. The Journal of Clinical Investigation 116: 115–124. doi:10.1172/JCI24335.

    Article  CAS  PubMed  Google Scholar 

  • Weyer, C., T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, and P.A. Tataranni. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology and Metabolism 86: 1930–1935. doi:10.1210/jcem.86.5.7463.

    Article  CAS  PubMed  Google Scholar 

  • Whitehead, J.P., A.A. Richards, I.J. Hickman, G.A. Macdonald, and J.B. Prins. 2006. Adiponectin—A key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism 8: 264–280. doi:10.1111/j.1463-1326.2005.00510.x.

    Article  CAS  PubMed  Google Scholar 

  • Wree, A., A. Kahraman, G. Gerken, and A. Canbay. 2011. Obesity affects the liver—The link between adipocytes and hepatocytes. Digestion 83: 124–133. doi:10.1159/000318741.

    Article  PubMed  Google Scholar 

  • Xi, L., Z. Qian, G. Xu, C. Zhou, and S. Sun. 2007. Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes. British Journal of Pharmacology 151: 610–617. doi:10.1038/sj.bjp.0707276.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xiao, X., Y. Dong, J. Zhong, R. Cao, X. Zhao, G. Wen, and J. Liu. 2011. Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose. Endocrine 40: 386–393. doi:10.1007/s12020-011-9531-9.

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi, T., and T. Kadowaki. 2008. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. International Journal of Obesity 2005(32 Suppl 7): S13–S18. doi:10.1038/ijo.2008.233.

    Article  CAS  Google Scholar 

  • Yamauchi, T., Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, and T. Kadowaki. 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine 13: 332–339. doi:10.1038/nm1557.

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi, T., M. Iwabu, M. Okada-Iwabu, and T. Kadowaki. 2014. Adiponectin receptors: A review of their structure, function and how they work. Best Practice & Research. Clinical Endocrinology & Metabolism 28: 15–23. doi:10.1016/j.beem.2013.09.003.

    Article  CAS  Google Scholar 

  • Ye, R., and P.E. Scherer. 2013. Adiponectin, driver or passenger on the road to insulin sensitivity? Molecular Metabolism 2: 133–141. doi:10.1016/j.molmet.2013.04.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang, Y., M. Matheny, S. Zolotukhin, N. Tumer, and P.J. Scarpace. 2002. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochimica et Biophysica Acta 1584: 115–122.

    Article  CAS  PubMed  Google Scholar 

  • Zhang, P., Y. Wang, Y. Fan, Z. Tang, and N. Wang. 2009. Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 67–74. doi:10.1161/ATVBAHA.108.178061.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, L., Z. Fu, J. Wu, K.W. Aylor, E.J. Barrett, W. Cao, and Z. Liu. 2015. Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses. The Journal of Physiology 593: 4067–4079. doi:10.1113/JP270371.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou, M., A. Xu, K.S.L. Lam, P.K.H. Tam, C.-M. Che, L. Chan, I.-K. Lee, D. Wu, and Y. Wang. 2010. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. Journal of Hepatology 53: 1108–1116. doi:10.1016/j.jhep.2010.05.034.

    Article  CAS  PubMed  Google Scholar 

  • Zoico, E., U. Garbin, D. Olioso, G. Mazzali, A.M. Fratta Pasini, V. Di Francesco, A. Sepe, L. Cominacini, and M. Zamboni. 2009. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3 T3-L1 adipocytes: Role of the NF-kappaB pathway. International Journal of Molecular Medicine 24: 847–851.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of General Surgery, Gazi University, Besevler, Ankara, Turkey

    Atilla Engin M.D., Ph.D.

  2. Mustafa Kemal Mah. 2137. Sok. 8/14, 06520, Cankaya, Ankara, Turkey

    Atilla Engin M.D., Ph.D.

Authors
  1. Atilla Engin M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atilla Engin M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Faculty of Pharmacy, Department of Toxicology, Gazi University, Hipodrom, Ankara, Turkey

    Ayse Basak Engin

  2. Faculty of Medicine, Department of General Surgery, Gazi University, Besevler, Ankara, Turkey

    Atilla Engin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Engin, A. (2017). Adiponectin-Resistance in Obesity. In: Engin, A., Engin, A. (eds) Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology, vol 960. Springer, Cham. https://doi.org/10.1007/978-3-319-48382-5_18

Download citation

Publish with us

Policies and ethics

Search

Navigation